Bernadette Dube

NPI: 1891114773
Total Payments
$2,547
2024 Payments
$886.78
Companies
32
Transactions
133
Medicare Patients
1,385
Medicare Billing
$102,889

Payment Breakdown by Category

Food & Beverage$2,547 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,547 133 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $420.22 20 $0 (2024)
Merck Sharp & Dohme LLC $274.49 15 $0 (2024)
Novartis Pharmaceuticals Corporation $252.36 16 $0 (2024)
ViiV Healthcare Company $226.32 11 $0 (2021)
Kowa Pharmaceuticals America, Inc. $144.97 9 $0 (2023)
Janssen Pharmaceuticals, Inc $139.52 8 $0 (2024)
Paratek Pharmaceuticals, Inc. $91.01 5 $0 (2023)
Azurity Pharmaceuticals, Inc. $82.87 5 $0 (2024)
Janssen Biotech, Inc. $79.69 4 $0 (2022)
PFIZER INC. $69.96 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $886.78 46 Novo Nordisk Inc ($192.38)
2023 $689.22 35 Novartis Pharmaceuticals Corporation ($116.70)
2022 $425.77 23 Novo Nordisk Inc ($97.53)
2021 $545.18 29 ViiV Healthcare Company ($226.32)

All Payment Transactions

133 individual payment records from CMS Open Payments — Page 3 of 6

Date Company Product Nature Form Amount Type
11/15/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.10 General
Category: Cardiovascular & Metabolism
10/24/2023 Azurity Pharmaceuticals, Inc. Edarbyclor (Drug) Food and Beverage Cash or cash equivalent $15.13 General
Category: Cardiology/Vascular Diseases
10/19/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $16.80 General
Category: Cardiology/Vascular Diseases
10/13/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.26 General
Category: Cardiovascular & Metabolism
09/20/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Cardiology/Vascular Diseases
09/19/2023 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $23.46 General
Category: Diabetes
09/15/2023 Seqirus USA Inc Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT Food and Beverage In-kind items and services $18.00 General
Category: Vaccines
09/09/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.94 General
Category: Cardiovascular & Metabolism
09/05/2023 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $27.38 General
Category: Iron Deficiency Anemia
08/22/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $15.02 General
Category: Cardiology/Vascular Diseases
08/18/2023 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $22.77 General
Category: Cardiology
08/18/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.06 General
Category: Cardiovascular & Metabolism
08/11/2023 Merck Sharp & Dohme LLC PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 Food and Beverage In-kind items and services $18.83 General
Category: VACCINE
08/09/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.17 General
Category: Diabetes
07/21/2023 Azurity Pharmaceuticals, Inc. Edarbyclor (Drug) Food and Beverage Cash or cash equivalent $15.42 General
Category: Cardiology/Vascular Diseases
07/10/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $14.81 General
Category: Cardiology/Vascular Diseases
07/07/2023 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $26.57 General
Category: Cardiology
06/29/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $22.68 General
Category: Diabetes
06/07/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $23.88 General
Category: INSOMNIA
06/06/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.33 General
Category: Cardiovascular and Metabolism
06/01/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $17.41 General
Category: Cardiology/Vascular Diseases
05/17/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $22.68 General
Category: Diabetes
05/03/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.06 General
Category: Cardiovascular & Metabolism
03/31/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $23.59 General
Category: Cardiology
03/21/2023 Regeneron Healthcare Solutions, Inc. EVKEEZA (Biological) Food and Beverage In-kind items and services $20.17 General
Category: CARDIOVASCULAR AND METABOLISM

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 50 55 $16,005 $2,207
2022 8 524 712 $151,020 $42,769
2021 9 479 651 $122,105 $39,449
2020 7 332 470 $65,675 $18,464
Total Patients
1,385
Total Services
1,888
Medicare Billing
$102,889
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 21 22 $7,920 $1,257 15.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 33 $8,085 $950.13 11.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 176 255 $62,475 $17,104 27.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 121 180 $64,800 $15,800 24.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 47 47 $16,440 $6,247 38.0%
90662 Influenza vaccine split virus, preservative free Office 2022 27 27 $2,255 $1,851 82.1%
G0008 Administration of influenza virus vaccine Office 2022 35 36 $2,545 $1,274 50.1%
36415 Insertion of needle into vein for collection of blood sample Office 2022 96 145 $2,175 $427.35 19.6%
96127 Assessment of emotional or behavioral problems Office 2022 11 11 $220.00 $41.57 18.9%
81003 Automated urinalysis test Office 2022 11 11 $110.00 $24.45 22.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 110 173 $53,800 $16,432 30.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 135 193 $41,660 $13,003 31.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 48 48 $15,825 $6,477 40.9%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 30 32 $4,160 $1,642 39.5%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 12 12 $960.00 $783.12 81.6%
G0008 Administration of influenza virus vaccine Office 2021 22 22 $1,540 $448.36 29.1%
36415 Insertion of needle into vein for collection of blood sample Office 2021 92 140 $2,100 $417.00 19.9%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 18 18 $1,800 $199.84 11.1%
96127 Brief emotional or behavioral assessment Office 2021 12 13 $260.00 $46.80 18.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 64 94 $24,840 $7,085 28.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 104 150 $27,845 $6,969 25.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 23 23 $6,550 $2,721 41.5%
90674 Vaccine for influenza for administration into muscle, 0.5 ml dosage Office 2020 20 20 $900.00 $584.60 65.0%
G0008 Administration of influenza virus vaccine Office 2020 23 23 $1,610 $454.25 28.2%
36415 Insertion of needle into vein for collection of blood sample Office 2020 80 142 $2,130 $419.25 19.7%

About Bernadette Dube

Bernadette Dube is a Family healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891114773.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bernadette Dube has received a total of $2,547 in payments from pharmaceutical and medical device companies, with $886.78 received in 2024. These payments were reported across 133 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,547).

As a Medicare-enrolled provider, Dube has provided services to 1,385 Medicare beneficiaries, totaling 1,888 services with total Medicare billing of $102,889. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Northport, NY
  • Active Since 04/08/2014
  • Last Updated 04/08/2014
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1891114773

Products in Payments

  • DOVATO (Drug) $226.32
  • LEQVIO (Drug) $198.61
  • Wegovy (Drug) $152.15
  • XARELTO (Drug) $139.52
  • Livalo (Drug) $131.29
  • NUZYRA (Drug) $91.01
  • Rybelsus (Drug) $87.99
  • CYCLOSET (Drug) $80.59
  • VERQUVO (Drug) $76.52
  • Repatha (Biological) $65.01
  • Ozempic (Drug) $63.69
  • GARDASIL (Biological) $61.14
  • FARXIGA (Drug) $59.56
  • DIFICID (Drug) $58.43
  • Heplisav-B (Drug) $56.37
  • Saxenda (Drug) $54.10
  • ENTRESTO (Drug) $53.75
  • PREVNAR 20 (Biological) $50.72
  • FUROSCIX (Drug) $49.34
  • INJECTAFER (Drug) $47.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Northport